KVC in the News

Federal Register: September 19, 2024 — FDA Sets New Priority Review User Fee Rate for FY 2025: $2,482,446

Blog: September 23, 2024 —U.S. House of Representatives Passes Give Kids a Chance Act, including the Creating Hope Reauthorization Act

September 21, 2024 — Climb the Hill Day

Two People Who Inspire Me

A rare disease program, portrayed as both lifeline and pharma handout, is set to expire

Mothers turn grief into action in the fight against childhood cancer

Podcast Episode 149: Nancy Goodman on Covid vaccines for kids, & Greg Zuckerman on Novavax's remarkable rise

Cures for All: US Lawmakers Should Give Drug Firms the Confidence to Test Cancer Therapies in Children

How to Correct the Market for Children’s Cancer Drugs, by Nancy Goodman

Editorial: Making paediatric precision oncology a reality, Octobert 2016

To Save Children with Cancer, Doctors Turn to New Weapons

New Legislation to Promote Paediatric Studies for New Cancer Medicines

Ruth Marcus: Out of Tragedy, Some Hope

Children with cancer get more access to experimental drugs, August 11, 2017

“TWiPO Episode 71” from Pediatric Cancer Advocacy with Nancy Goodman from Kids v Cancer by Tim Cripe.

Podcast Episode from Help and Hope Happen Here interview with Nancy Goodman

Interview with Nancy Goodman. November 17, 2021

US FDA Could Require Pediatric Cancer Drug Combo Studies Under Amended User Fee Bill

Law offers drug companies vouchers in exchange for new cancer drugs for kids

Everyday Heroes

Giving and getting: Mom turns son's death into new rare-disease drug voucher program

Hope for children's rare drug approval process

For Children With Cancer, Hope for New Treatments

Why Can’t Dying Patients Get the Drugs They Want?

How one drug company fast-tracked the FDA’s review process

How To Get A Bill Through Congress_ Pediatric Cancer Treatment Advocate Scores 2 Wins, 1 Loss, January 5, 2023

House Panel Advances FDA User FeeBill, Teeing Up Full Vote